Subcutaneous somatotropin vs placeboTime from beginning of treatment until death or full‐time ventilation · children and adults with SMA types II and III1 finding from 1 reviewDrug treatment for spinal muscular atrophy types II and III 2020 · Cochrane Headline outcomes onlyno estimate extracted19 participantsLow